4.7 Article

A histone deacetylase inhibitor, largazole, decreases liver fibrosis and angiogenesis by inhibiting transforming growth factor-β and vascular endothelial growth factor signalling

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Biochemistry & Molecular Biology

Total synthesis of largazole and analogues: HDAC inhibition, antiproliferative activity and metabolic stability

Hanae Benelkebir et al.

BIOORGANIC & MEDICINAL CHEMISTRY (2011)

Article Gastroenterology & Hepatology

Hepatic Stellate Cells Secrete Angiopoietin 1 That Induces Angiogenesis in Liver Fibrosis

Kojiro Taura et al.

GASTROENTEROLOGY (2008)

Review Gastroenterology & Hepatology

Mechanisms of hepatic fibrogenesis

Scott L. Friedman

GASTROENTEROLOGY (2008)

Article Chemistry, Multidisciplinary

Total synthesis and biological mode of action of largazole: A potent Class I histone deacetylase inhibitor

Albert Bowers et al.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2008)

Article Chemistry, Multidisciplinary

Structure and activity of largazole, a potent antiproliferative agent from the Floridian marine cyanobacterium Symploca sp.

Kanchan Taori et al.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2008)

Review Gastroenterology & Hepatology

Sinusoidal remodeling and angiogenesis: A new function for the liver-specific pericyte?

June Sung Lee et al.

HEPATOLOGY (2007)

Article Gastroenterology & Hepatology

TGF-β1 modulates matrix metalloproteinase-13 expression in hepatic stellate cells by complex mechanisms involving p38MAPK, PI3-kinase, AKT, and p70S6k

CG Lechuga et al.

AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2004)

Review Biochemistry & Molecular Biology

The biology of VEGF and its receptors

N Ferrara et al.

NATURE MEDICINE (2003)

Article Gastroenterology & Hepatology

Inhibition of rat liver fibrogenesis through noradrenergic antagonism

L Dubuisson et al.

HEPATOLOGY (2002)